Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer-Reference-Cited by-同舟云学术

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer

Published:2016 Issue:3 Volume:19 Page:242
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Bae Sang Byung¹,Cho Hyun Deuk²,Oh Mee-Hye²,Lee Ji-Hye²,Jang Si-Hyong²,Hong Soon Auck²,Cho Junhun²,Kim Sung Yong³,Han Sun Wook³,Lee Jong Eun³,Kim Han Jo¹,Lee Hyun Ju²

Affiliation:

1. Department of Hemato-Oncology, Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

2. Department of Pathology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

3. Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

Funder

Soonchunhyang University

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

http://synapse.koreamed.org/pdf/10.4048/jbc.2016.19.3.242

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of Tumor-Infiltrating Lymphocytes in Breast Carcinoma and Their Association With Pathological and Prognostic Factors and Pathological Tumor-Node-Metastasis (pTNM) Staging;Cureus;2024-08-11

2. Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq;European Journal of Medical Research;2024-07-05

3. PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis;Cancer Cell International;2024-05-09

4. Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy;Frontiers in Immunology;2024-04-29

5. High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype;2024-01-31